scholarly journals Clients’ Perception of Quality of Multidrug-Resistant Tuberculosis Treatment and Care in Resource-Limited Setting: Experience from Nigeria

Author(s):  
Olanrewaju Oladimeji ◽  
Daniel Adedayo Adeyinka ◽  
Lehlogonolo Makola ◽  
Kabwebwe Honoré Mitonga ◽  
Ekerette Emmanuel Udoh ◽  
...  
Author(s):  
Laura N. Purcell ◽  
Rachel Reiss ◽  
Mercy Mtalimanja ◽  
Patricia Kuyenda ◽  
Vanessa Msosa ◽  
...  

2015 ◽  
Vol 191 (3) ◽  
pp. 355-358 ◽  
Author(s):  
Mathieu Bastard ◽  
Maryline Bonnet ◽  
Philipp du Cros ◽  
Atadjan Karimovich Khamraev ◽  
Armen Hayrapetyan ◽  
...  

2019 ◽  
Vol 12 (8) ◽  
pp. e230628 ◽  
Author(s):  
Christian Francisco ◽  
Mary Ann Lansang ◽  
Edsel Maurice Salvana ◽  
Katerina Leyritana

Tuberculosis (TB) is common among persons living with HIV. This public health concern is aggravated by infection with multidrug-resistant organisms and adverse effects of polypharmacy. There are few published cases of multidrug-resistant tuberculosis (MDR-TB) in multidrug-resistant HIV (MDR-HIV) infected patients. We report a case of a 29-year-old Filipino man with HIV on zidovudine (AZT)-containing antiretroviral therapy (ART) but was eventually shifted to tenofovir due to anaemia. He presented with left flank tenderness, which was found to be due to an MDR-TB psoas abscess, and for which second-line anti-TB treatment was started. HIV genotyping showed MDR-HIV infection susceptible only to AZT, protease inhibitors and integrase inhibitors. Subsequently, he developed neck abscess that grew Mycobacterium avium complex and was treated with ethambutol and azithromycin. ART regimen was revised to AZT plus lamivudine and lopinavir/ritonavir. Erythropoietin was administered for recurrent AZT-induced anaemia. Both abscesses resolved and no recurrence of anaemia was noted.


Sign in / Sign up

Export Citation Format

Share Document